StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.29−0.14 (-0.88%)

Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –

Rallybio operating margin

Operating margin is operating income as a percentage of revenue.

Rallybio's operating margin for the twelve months ending Sep 30, 2026 was -5580.9%. For fiscal 2025 it was -3853.6%, against -9511.9% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-3853.6%+5658.3
FY2024Dec 31, 2024-9511.9%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 2026-4119.3%+442.0
Q4 FY2025Dec 31, 2025-2888.3%+27659.1
Q3 FY2025Sep 30, 2025-3266.5%+768.9
Q2 FY2025Jun 30, 2025-4743.9%+953.5
Q1 FY2025Mar 31, 2025-4561.3%–
Q4 FY2024Dec 31, 2024-30547.4%–
Q3 FY2024Sep 30, 2024-4035.5%–
Q2 FY2024Jun 30, 2024-5697.3%–

More Rallybio figures

See a number that looks wrong?